These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5077398)

  • 1. [Control of continuous heparinization by active coagulation time (ACT). Application to prolonged extracorporeal circulation].
    de Leval M; Hill JD; Dontigny L; Gerbode F
    Ann Chir Thorac Cardiovasc; 1972 Sep; 11(3):287-90. PubMed ID: 5077398
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual responses to heparinization for extracorporeal circulation.
    Friesen RH; Clement AJ
    J Thorac Cardiovasc Surg; 1976 Dec; 72(6):875-9. PubMed ID: 994537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Method of control of the artificial heparinization of blood].
    Iunovidova LI; Savina ME; Kukaeva EA
    Lab Delo; 1985; (11):657-9. PubMed ID: 2417016
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of GBH-coated Tygon tubing for experimental prolonged perfusions without systemic heparinization.
    Indeglia RA; Dorman FD; Castaneda AR; Varco RL; Bernstein EF
    Trans Am Soc Artif Intern Organs; 1966; 12():166-73. PubMed ID: 5960696
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activated coagulation time during extracorporeal circulation: useful for reducing the use of homologous blood?].
    Brandi LS; Benedetti M; Russo V; Grana M; Mosca F
    Minerva Anestesiol; 1984 Apr; 50(4):127-32. PubMed ID: 6472644
    [No Abstract]   [Full Text] [Related]  

  • 9. [Routine heparinization and activated clotting time (ACT) in patients operated on under extracorporeal circulation].
    Kalawski R; Krzyś T; Leciej M
    Wiad Lek; 1982 Oct; 35(18):1119-24. PubMed ID: 7179984
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prolonged heparinless venoarterial bypass on blood coagulation in sheep.
    Wakabayaski A; Woolley TO; Nakamura Y; Connolly JE
    Surg Forum; 1975; 26():250-2. PubMed ID: 1216128
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of bound heparin in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Zwischenberger JB; Oram AD; DeSmet GM; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1984; 30():133-6. PubMed ID: 6533877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum heparin concentration during extracorporeal circulation].
    Neef H; Pauer HD
    Thoraxchir Vask Chir; 1970 Dec; 18(6):497-502. PubMed ID: 5275549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Control of blood coagulation in extracorporeal circulation].
    Neef H
    Med Klin; 1971 Jan; 66(1):16-21. PubMed ID: 5545364
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of adequate heparinization during artificial circulation in the framework of prolonged intraoperative administration of high doses of aprotinin].
    Dement'eva II; Charnaia MA; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1994; (3):32-5. PubMed ID: 7521582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats.
    Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H
    Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.